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Abstract 
Protein-ligand titrations can readily be monitored with a trimethylsilyl (TMS) tag. Owing to the 
intensity, narrow line shape and unique chemical shift of a TMS group, dissociation constants 
can be determined from straightforward 1D 1H-NMR spectra not only in the fast but also in the 
slow exchange limit. The tag is easily attached to cysteine residues and a sensitive reporter of 
ligand binding also at sites where it does not interfere with ligand binding or catalytic efficiency 
of the target protein. Its utility is demonstrated for the Zika virus NS2B-NS3 protease and the 
human prolyl isomerase FK506 binding protein.  
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Introduction 
Drug discovery critically depends on the identification of suitable lead compounds 
among the vast pool of candidates evaluated during extensive screening or elaboration 
campaigns. Specificity of binding and binding affinity to the drug target are two essential 
parameters defining a lead compound. Nuclear magnetic resonance (NMR) spectroscopy is 
uniquely positioned to assess both parameters simultaneously and, consequently, has become an 
important tool in the pharmaceutical industries to screen, identify and validate small molecules 
as potential lead candidates (Gossert and Jahnke 2016). In recent years, NMR spectroscopy has 
gained particular importance in the early stages of the drug discovery process, where fragment-
based lead discovery has proven an efficient approach to identify small ligands that bind to the 
target biomolecule (Doak et al. 2016). In this context, the main focus is often on weakly binding 
ligand molecules that are in rapid exchange between bound and free state. In subsequent stages 
of the drug discovery process, however, alternative methods are necessary to analyze the binding 
epitope and determine the affinity of elaborated ligands, which are usually in slow chemical 
exchange on the NMR time scale (Nitsche and Otting 2018).  
Although 2D NMR spectra with uniformly 15N-labeled target proteins are considered to 
be the NMR ‘gold standard’ to assess ligand binding in both early and later stages of the drug 
discovery process, several alternative strategies have been developed that do not rely on 
expensive isotope labeling and require significantly smaller protein quantities. A prominent 
example is the use of 1D 19F-NMR spectroscopy to detect fluorine-substituted tryptophan, 
trifluoromethoxy-L-phenylalanine, or cysteine residues, that were post-translationally furnished 
with a CF3 group, in the target protein (Jackson et al. 2007; Cellitti et al. 2008; Arntson and 
Pomerantz 2016; Liu et al. 2012). The large chemical shift anisotropy associated with 19F spins 
imparts high sensitivity towards changes in the environment but is also a source of line 
broadening. 1H-NMR spectra offer intrinsically higher sensitivity and, in practice, most NMR 
spectrometers are equipped for 1H-NMR but not always for 19F-NMR spectroscopy. The greater 
sensitivity of 1H-NMR spectra, however, comes at the expense of spectral overlap between 
protein and ligand signals, which makes it harder to quantify the protein-ligand interactions from 
1D NMR spectra. To a large extent, this problem can be alleviated by labels with a tertiary butyl 
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(tBu) group that produces an exceptionally narrow and intense NMR signal arising from nine 
methyl protons with degenerate chemical shift. This often makes it possible to assign and track 
tBu signals in the presence of modest spectral overlap with protein signals. Recent examples 
have demonstrated this for ligands containing a tBu group and proteins containing a site-
selectively incorporated tBu-tyrosine residue (Chen et al. 2015; Chen et al. 2016; Jabar et al. 
2017). When the spectral overlap is pronounced, however, the 1H-NMR signal even of a tBu 
group may be difficult to identify and track. Even more limiting, spectral overlap prevents 
accurate integration of the tBu resonance, compromising quantitative evaluation of any titration 
experiments, where the ligand is in slow exchange between bound and free state.  
Here we present a strategy that relies on the unique 1H chemical shift of a trimethylsilyl 
(TMS) group near 0 ppm, where spectral overlap with protein signals is much less severe than at 
the chemical shift of a tBu group (which is at about 1.3 ppm). Previously, we investigated the 
possibility of site-specific incorporation of p-TMS-phenylalanine (TMSf) by genetic encoding 
but, due to ring currents, the TMS signal appeared at about 0.3 rather than 0 ppm and the amino 
acid could not be incorporated in high yield (Loh et al. 2018). Furthermore, the signal proved to 
be prone to extreme line broadening, when a target protein containing TMSf was titrated with a 
low molecular weight ligand, which may be attributed to the overall rigidity of the TMSf amino 
acid. To alleviate these drawbacks, we designed a tag that is identical to the TMS tag 1 (Figure 
1) except that it contains an amide rather than an ester group. Following attachment to a single 
cysteine residue in the E. coli single-stranded DNA binding protein, the amide tag enabled the 
observation of intermolecular nuclear Overhauser effects (NOEs) with single-stranded DNA 
(Jabar et al. 2017). In other proteins, however, the tag proved prone to peak doubling, which 
could be attributed to cis/trans amide bond isomerization. 
The new TMS tag 1 (Figure 1) solves this problem by containing a more flexible ester 
moiety. It can be selectively attached to solvent-exposed cysteine residues by generating a redox-
stable thioether bond between tag and protein. It produces a single TMS signal at a chemical 
shift near 0 ppm. Its 1H-NMR signal is easy to detect and, owing to its chemical shift in a 
spectral region with few protein peaks, its intensity can readily be quantified. This makes the tag 
ideal for monitoring ligand binding events both in the fast and slow exchange regimes with small 
quantities of protein and ligand. We demonstrate the approach for two different drug targets, the 
Zika virus NS2B-NS3 protease (ZiPro) and the human prolyl isomerase FK506 binding protein 
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(FKBP). ZiPro is closely related to the NS2B-NS3 proteases of a range of flaviviruses such as 
dengue and West Nile viruses, which cause regular epidemic outbreaks (Boldescu et al. 2017). 
The NS2B-NS3 proteases catalyze the post-translational processing of the viral precursor 
polyprotein into smaller protein units, which are essential for viral replication (Nitsche et al. 
2014). Based on previous successes with HIV and HCV protease inhibitors, flaviviral proteases 
are promising drug targets, but drug development has been frustrated by the polar character of 
substrate-derived inhibitors, a shallow substrate binding site, and a lack of structural elucidation, 
and only few inhibitors have been identified for ZiPro (Boldescu et al. 2017; Nitsche et al. 2014). 
Human FKBP is the target of the immunosuppressive drugs tacrolimus (FK-506) and rapamycin, 
which suppress organ rejection after allogeneic transplantations (Siekierka et al. 1989). FKBPs 
are involved in multiple regulatory pathways, offering prospects for prevention and treatment of 
a broad range of diseases (Bonner and Boulianne 2017). 
 
Materials and Methods 
Synthesis of the trimethylsilyl tag 
Details of the protocol for the chemical synthesis of the trimethylsilyl tag 1 (Figure 1) are given 
in the Supporting Information. 
 
Preparation of the wild type and V36C mutant of the Zika virus NS2B-NS3 protease  
The construct of the Zika virus NS2B-NS3 protease (ZiPro) has been described previously 
(Mahawaththa et al. 2017; Nitsche et al. 2017). Briefly, it includes 48 hydrophilic core residues 
of NS2B (residues 48*–95*, where the star indicates residues in NS2B) followed by a 
Gly4SerGly4 linker, the N-terminal residues of the NS3 protease domain (residues 1–170), and a 
His6 tag. The mutations R95*A, K15N, R29G, C80S and C143S were introduced to increase 
stability, reduce the potential of auto-cleavage, and avoid dimerization (Lei et al. 2016; 
Mahawaththa et al. 2017; Nitsche et al. 2017). This construct is referred to as wild type. The 
mutation V36C was introduced for selective ligation of compound 1 to position 36. The 
expression construct used the T7 expression vector pETMCSI (Neylon et al. 2000). The plasmid 
was transformed into E. coli BL21(DE3) and cells were grown in LB medium containing 
ampicillin at 37 °C until an OD600 value of 0.5-0.8 was reached. Subsequently, overexpression 
was induced with IPTG (1 mM) and the cells were incubated overnight at room temperature. The 
 5 
 
cells were pelleted by centrifuging at 5000 g for 10 minutes and lysed by passing twice through a 
French Press (SLM Aminco, USA) at 830 bars. The cell lysate was centrifuged for 1 h at 
34,000 g and the supernatant was loaded onto a 5 ml Ni-NTA column (GE Healthcare, USA) 
pre-equilibrated with loading buffer (50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 10% glycerol). 
The protein was eluted with a gradually increasing concentration of elution buffer (50 mM Tris-
HCl, pH 7.5, 300 mM NaCl, 300 mM imidazole, 10% glycerol), fractions were analyzed by 12% 
SDS-PAGE, and the buffer was exchanged to 20 mM MES, pH 6.5, 150 mM NaCl. 
 
Preparation of FKBP R18C 
A construct of the human prolyl isomerase FK506 binding protein (FKBP) with C-terminal His6 
tag was incorporated into a pCDF-1b vector (Novagen) using the restriction sites NcoI and NotI. 
The additional mutations C22S and R18C were introduced for site-selective tagging of position 
18 with compound 1. The plasmid was transformed into E. coli BL21(DE3) and cells were 
grown in LB medium containing streptomycin at 37 °C until an OD600 value of 0.5-0.8 was 
reached. Overexpression was induced with IPTG (1 mM) and the cells were incubated overnight 
at room temperature. The cells were pelleted by centrifuging at 5000 g for 10 minutes and lysed 
by passing twice through a French Press at 830 bars. The cell lysate was centrifuged for 1 h at 
34,000 g and the supernatant was loaded onto a 5 ml Ni-NTA column (GE Healthcare, USA) 
pre-equilibrated with loading buffer (50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 10% glycerol, 5 
mM 2-mercaptoethanol). The protein was eluted with a gradually increasing concentration of 
elution buffer (50 mM Tris-HCl, pH 7.5, 300 mM NaCl, 300 mM imidazole, 10% glycerol, 5 
mM 2-mercaptoethanol) and fractions were analyzed by 12% SDS-PAGE. The buffer was 
exchanged to buffer A (50 mM sodium phosphate buffer, pH 6.5, 150 mM NaCl, 5 mM 2-
mercaptoethanol), and the protein was loaded onto a GE Superdex 75 (HiLoad 16/60) size 
exclusion column and eluted with buffer A. 
 
Tagging procedure  
ZiPro V36C and FKBP R18C samples were treated with DTT (2 mM) for 1 h at room 
temperature, before the buffer was exchanged to buffer A (20 mM MES, pH 6.5, 150 mM NaCl, 
10% glycerol). 100 µM samples were subsequently incubated with compound 1 (500 µM, 10 
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mM DMSO stock) overnight at room temperature. The buffer was changed to NMR buffer 
(20 mM MES, pH 6.5, 150 mM NaCl, 10% D2O).  
 
 
NMR measurements and Kd determination 
All protein NMR spectra were recorded in 3 mm NMR tubes at 25 °C, using an 800 MHz Bruker 
Avance III NMR spectrometer equipped with a 5 mm TCI cryoprobe. Each titration step added 
ligand from a concentrated DMSO stock and a 1H-NMR spectrum was recorded with water 
suppression by the double spin-echo sequence (Hwang and Shaka 1995), using 512 scans per 
spectrum with a recovery delay of 1.3 seconds. The spectra were calibrated with respect to the 
water frequency. A control experiment with DMSO alone added at the concentration of the final 
titration point confirmed that solvent-induced chemical shift changes were insignificant. In the 
case of fast chemical exchange (FKBP), the dissociation constant was determined from the 
change in chemical shift of the TMS signal observed during titration with ligand. In the case of 
slow chemical exchange (ZiPro), the dissociation constant was determined from the change in 
relative peak intensities of the TMS signal of the complex, where the peak height of the TMS 
peak was divided by the overall integral of the spectral region between 0.5 and 0.9 ppm.  
 
 
Results and Discussion  
Tag synthesis and tagging reaction 
The TMS tag 1 was readily synthesized in large quantities via only two synthetic steps (Scheme 
S1). The purity of the synthesized compounds was ≥ 95%. Quantitative and selective alkylation 
of single cysteine residues in the target proteins was achieved at neutral pH without any 
additional reagents, except that the TMS tag was added dissolved in DMSO.  
 
Zika virus NS2B-NS3 protease 
To study inhibitor binding at the active site of ZiPro, we installed the TMS group close to the 
catalytic center formed by Ser135, His51, and Asp75 (Figure 2). Visual inspection of the crystal 
structure of ZiPro (PDB code: 5LC0) (Lei et al. 2016) suggested Val36 as a suitable residue for 
tagging, which was consequently mutated to cysteine. To avoid cross-reactivity with the solvent-
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exposed residues Cys80 and Cys143 in the wild-type amino-acid sequence, these residues were 
mutated to serine residues as in previous studies of ZiPro (Lei et al. 2016; Mahawaththa et al. 
2017; Nitsche et al. 2017). These mutations were present in all ZiPro constructs used in this 
work and we refer, in the following, to the double-mutant C80S/C143S as wild type and the 
triple-mutant V36C/C80S/C143S as ZiPro V36C. Reduced ZiPro V36C readily reacted with the 
TMS tag 1 as confirmed by high-resolution mass spectrometry (Figure S2). Figure 2 illustrates 
the attachment site of 1 relative to the active site of ZiPro. The high solvent exposure of 1 entails 
high flexibility of the tag, which supports a narrow line shape of its TMS signal in the 1H-NMR 
spectrum and, therefore, high sensitivity.  
To confirm that the installation of a TMS tag adjacent to the active site has no significant 
influence on substrate binding and enzymatic reactivity, we compared the kinetic parameters Km 
and kcat of the tagged mutant with wild-type ZiPro (Table 1, Figure S1). Both proteins displayed 
similar Km values, indicating unencumbered substrate binding. Equally, the kcat values were only 
marginally different, with a slight kcat increase for the tagged protease compared to the wild type, 
and the overall catalytic efficiencies (kcat/Km) were indistinguishable. This indicates that the 
presence of the tag presents no significant perturbation. The 1H-NMR spectrum of tagged ZiPro 
only showed a single narrow TMS peak at about 0.06 ppm (Figure 3) as expected for a 
homogeneous sample, which was subsequently used for titration with the ligand 2. 
Compound 2, which is known as an active-site inhibitor of flaviviral proteases (de la 
Cruz et al. 2011; Nitsche et al. 2014; Brecher et al. 2017), was chosen as a model ligand to assess 
the performance of the TMS tag 1 in a ligand titration experiment. Inhibition experiments 
revealed IC50 values of about 160 µM for the wild type and the tagged mutant V36C (Table 1). 
This value is two orders of magnitude higher than reported previously (Lim et al. 2016), but the 
similarities of the IC50 values determined under identical conditions for the tagged and wild type 
versions (Table 1) clearly indicate that the TMS tag at position 36 does not influence the 
intermolecular recognition and binding interaction.  
Titration of tagged ZiPro V36C with compound 2 led to the appearance of a new TMS 
peak for the complex while the original TMS peak of the free protein weakened and disappeared 
(Figure 3), showing that the ligand exchanges slowly on the NMR time scale in agreement with 
previous observations (Mahawaththa et al. 2017). A second, smaller TMS peak appearing further 
up-field was attributed to a complex with the hydrolysis products of compound 2, which is prone 
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to hydrolysis in aqueous solution and proteolytic cleavage by proteases. Hydrolysis of 2 was 
detected by the gradual emergence of the characteristic yellow color of p-nitrophenolate during 
the titration. An additional smaller TMS peak was not observed in the titration experiments with 
FKBP, indicating that the ester bond of the TMS tag is stable. After 24 h at 25 oC, however, the 
FKBP sample displayed two additional small TMS signals with integrals less than 10% of the 
main peak, which may be attributed either to partial hydrolysis of the tag or protein degradation. 
Determining the Kd value in situations of slow exchange is difficult, as it requires low 
protein concentrations in the vicinity of the dissociation constant. This presents a problem, as the 
low sensitivity of NMR spectroscopy demands relatively high sample concentrations. The high 
sensitivity afforded by the 1H-NMR signal of the TMS group thus presents a clear advantage. 
For example, 1D NMR spectra of a 75 µM solution of tagged ZiPro provided excellent signal-to-
noise ratios already within a few minutes. In view of the IC50 values, we expected a dissociation 
constant Kd in the two- to three-digit micromolar range. In the slow exchange regime, the Kd 
value can be determined using  
 
 
 
where I denotes the TMS peak intensity of the complex and Imax the TMS peak intensity 
observed for the fully saturated complex, and [L] and [P] are the concentrations of ligand and 
protein, respectively. As the intensity of only a single TMS peak is monitored, the approach is 
independent of its T1 and T2 relaxation times, so long as excess ligand does not modify the 
properties of the complex. Apparent peak intensities can vary, however, if the NMR sample is 
removed from the magnet and re-inserted for each titration step. Therefore, it proved important 
to reference the intensity of the TMS peak to an internal standard. While, in principle, the 
integral of the TMS peak of the complex could be compared with the sum of the integrals of the 
TMS signals of the complex and free protein, more reliable measurements were obtained by 
normalizing the peak height of the TMS peak of the complex (measured with local baseline 
correction to establish the base of the peak) by the overall integral of the methyl region of the 
NMR spectrum (0.5–0.9 ppm). Figure 4 shows the fit of the NMR titration data to equation (1), 
revealing a Kd value of 64 ± 27 µM for compound 2. 
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FKBP 
To validate the utility of the tag for a different protein-ligand complex, we investigated FKBP as 
a second model system with two different ligands (3 and 4), which are weakly and tightly 
binding inhibitors. For site-specific tagging of FKBP with compound 1 adjacent to the binding 
site of inhibitor 3, the natural cysteine residue in position 22 was mutated to serine and the 
solvent-exposed residue Arg18 was mutated to cysteine for tagging (Figure 5). FKBP R18C was 
readily and selectively tagged with compound 1, as confirmed by mass spectrometry (Figure S3). 
In contrast to the experiments conducted with ZiPro and ligand 2, ligand 3 was stable during the 
experiment and the TMS signal shifted gradually with increasing ligand concentration, 
maintaining a single peak throughout the titration experiment (Figure 6). Compound 3 has 
previously been identified as low-molecular weight ligand for FKBP by 2D NMR methods, 
where residues in the binding site highlighted in Figure 5 displayed the characteristics of fast 
chemical exchange (Shuker et al. 1996). Our data confirm the fast exchange situation and allow 
determination of the Kd value from simple 1D NMR spectra (Figure 7).  
The dissociation constant of the complex of FKBP with compound 3 has been reported 
previously as 0.1 mM (Shuker et al. 1996). To determine the Kd value, the titration curve of 
Figure 7 was fitted using  
 
 
 
where Dd is the observed chemical shift difference, Ddmax the maximal chemical shift difference 
at saturation, and [L] and [P] are the concentrations of ligand and protein, respectively. The fitted 
curve shown in Figure 7 determined a Kd value of 94 ± 10 µM, which is in excellent agreement 
with the value reported previously (Shuker et al. 1996). 
Finally, we tested the TMS tag for its capability to monitor binding events remote from 
the tagging site. We chose the drug rapamycin (4), which binds to FKBP with very high affinity 
(Ki = 0.2 nM) at a site far from the TMS tag (Figure 5) (Bierer et al. 1990). Dissociation 
constants in the subnanomolar concentration range cannot be determined by conventional NMR 
experiments. The actual binding event, however, was very clearly detected by the TMS signal 
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(Figure 8). The tag thus offers a sensitive probe not only for Kd determinations, but also for the 
detection of binding events between large biomolecules without a requirement of immediate 
proximity to the binding interface. 
 
Concluding remarks 
The binding affinity is a very important validation parameter for any further development of lead 
candidates in drug discovery. Quite generally, using NMR to monitor the target protein during 
titration experiments has the great advantage of reporting not only on ligand binding but also the 
continued integrity of the protein towards aggregation and unfolding. NMR spectroscopy of 
uniformly isotope-labeled proteins thus is routinely used to detect binding and measure 
dissociation constants, but this is difficult for very large proteins and proteins that cannot easily 
be enriched with stable isotopes. The chemical tag presented here capitalizes on the chemical 
shift of the TMS group in a spectral region that contains few 1H-NMR signals of the protein and 
therefore enables accurate measurement of peak intensities. It is easy to use, detects binding with 
high sensitivity, and allows the quantitative measurement of dissociation constants not only in 
the fast but also the slow exchange regime. In the slow exchange limit, it is necessary to quantify 
the peak intensity and this is difficult when the peak is not in a spectral region with minimal 
signal overlap, as the protein spectrum changes step-wise in response to added ligand and 
therefore the baseline may not always be easy to identify. We anticipate that the simplicity of the 
tag, tagging reaction, and NMR detection will make the TMS tag 1 popular in different stages of 
the drug discovery process for proteins containing a single reactive cysteine residue. Work is in 
progress to broaden the approach by genetic encoding of an unnatural amino acid containing a 
TMS group with a chemical shift near 0 ppm. 
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Table 1. Kinetic and inhibition parameters of wild-type ZiPro and ZiPro V36C tagged with the 
TMS probe 1. 
 
Km  
(µM) 
kcat  
(s–1) 
kcat/Km 
(106·s–1·M–1) 
IC50  
(µM)d 
ZiPro (wt)a 2.4 ± 0.3 8.6 ± 0.1 3.6 (3.2 – 4.1)c 160 ± 8 
ZiPro (V36C) + tag 1b 2.5 ± 0.3 10.5 ± 0.4 4.2 (3.7 – 4.9)c 158 ± 22 
a Zika virus protease C80S/C143S  
b Zika virus protease C80S/C143S/V36C with covalently attached tag 1 at position 36. 
c Uncertainty range determined by error propagation. 
d Half maximal inhibitory concentration of compound 2 at 10 µM substrate concentration. 
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Figures 
 
Figure 1.  Chemical structures of the TMS tag and ligands used in this study. 1: Cysteine-
reactive TMS tag. 2: 4-Nitrophenyl 4-guanidinobenzoate, which is an active-site inhibitor of the 
Zika virus NS2B-NS3 protease (ZiPro). 3: 4-Hydroxy-N-(4-hydroxyphenyl)benzamide, which is 
a low-affinity FKBP ligand. 4: Rapamycin, which is a high-affinity FKBP ligand.  
 
 
 
 
Figure 2.  Active site of the Zika virus NS2B-NS3 protease showing the TMS tag 1 (green) 
attached at position 36 and the side-chains of the catalytic triad (Ser135, His51, Asp75). Sulfur is 
highlighted in yellow, oxygen in red, nitrogen in blue, and silicon in magenta. NS3 is shown in 
beige and NS2B in blue. 
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Figure 3.  1D 1H-NMR spectra monitoring the titration of ZiPro (75 µM in 20 mM MES buffer, 
pH 6.5, containing 150 mM NaCl) with inhibitor 2. The spectra were recorded on an 800 MHz 
NMR spectrometer. We assign the original TMS peak at 0.06 ppm and the new peak at 0.03 ppm 
(labeled with an arrow and used to calculate the binding affinity, see Figure 4) to free ZiPro and 
ZiPro in complex with 2, respectively. The star identifies a minor species attributed to an 
interaction with hydrolyzed compound 2. The titration ratios of protein to ligand are indicated. 
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Figure 4.  Titration curve for ZiPro and inhibitor 2 based on the NMR spectra shown in Figure 
3. The peak intensity of the new TMS peak (identified by an arrow in Figure 3) against the 
concentration of compound 2. The fit of equation (1) determined a Kd value of 64 ± 27 µM. 
Errors were calculated with respect to signal-to-noise ratios. 
 
 
Figure 5. Structure of FKBP modeled with the TMS tag 1 (green) attached to R18C. Sulfur is 
highlighted in yellow, oxygen in red, nitrogen in blue, and silicon in magenta. The binding site 
for inhibitor 3 is highlighted in red. Rapamycin (4) is shown in cyan. 
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Figure 6.  1D 1H-NMR spectra of a 130 µM solution of FKBP in 20 mM MES buffer, pH 6.5, 
and 150 mM NaCl, monitoring the titration with ligand 3. The spectra were recorded on an 800 
MHz NMR spectrometer. The gradual change in the chemical shift of the TMS peak was used to 
calculate the binding affinity (Figure 7). The titration ratios of protein to ligand are indicated. 
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Figure 7.  Titration curve plotting the chemical shift changes observed for the TMS peak in 
response to increasing concentrations of compound 3 (Figure 6). A fit of equation (2) determined 
a Kd value of 94 ± 10 µM. Error bars reflect an estimated uncertainty in chemical shift of ±1 Hz. 
 
 
 
 
 
Figure 8.  1D 1H-NMR spectra of FKBP with different ratios of FKBP to the tightly binding 
ligand rapamycin (4), using the same sample conditions and NMR spectrometer as in Figure 6. 
 
 
 
